Unique ID issued by UMIN | UMIN000030169 |
---|---|
Receipt number | R000034418 |
Scientific Title | Persistence rate of out-patients visit in glaucoma patients |
Date of disclosure of the study information | 2017/11/30 |
Last modified on | 2020/10/16 16:01:57 |
Persistence rate of out-patients visit in glaucoma patients
Persistence rate of out-patients visit in glaucoma patients
Persistence rate of out-patients visit in glaucoma patients
Persistence rate of out-patients visit in glaucoma patients
Japan |
Glaucoma
Ophthalmology |
Others
NO
To assess the improving effects of anti-dropout tool on the persistence rate of patients who was newly diagnosed as glaucoma.
Others
To assess the improving effects of anti-dropout tool on the persistence rate of patients who was newly diagnosed as glaucoma.
Persistence rate of out-patients visit after loading tool.
Observational
Not applicable |
Not applicable |
Male and Female
Phase 1
Newly diagnosed glaucoma patients for April 2016 to May 2016 at clinics introducing of tool.
Phase 2
Newly diagnosed glaucoma patients for April 2017 to May 2017 at clinics which persistence rate of out-patients visit is under 70.0% in Phase 1.
Not applicable
120
1st name | Kiyotaka |
Middle name | |
Last name | Hori |
Santen Pharmaceutical Co., Ltd.
Japan Medical Affairs, Development Management Department, Japan Business
530-8552
4-20, Ofukacho, Kita-ku, Osaka
06-4802-9337
clinical@santen.co.jp
1st name | Naomi |
Middle name | |
Last name | Otsuka |
Santen Pharmaceutical Co., Ltd.
Japan Medical Affairs, Development Management Department, Japan Business
530-8552
4-20, Ofukacho, Kita-ku, Osaka
06-4802-9603
clinical@santen.co.jp
Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd.
Profit organization
Non-Profit Organization MINS Institutional Review Board
ST Shibuya Building 1-15-14, Dogenzaka, Shibuya-ku, Tokyo
03-6416-1868
npo-mins@j-irb.com
NO
2017 | Year | 11 | Month | 30 | Day |
Published
156
The glaucoma patient visit persistence support system has proven to be effective in maintaining the persistence of the patients visits for newly diagnosed glaucoma.
Intraocular pressure after the implementation of this support system was significantly lower than at the time of the first visit, suggesting the usefulness of this system for the treatment of glaucoma.
(Ganka. 2020,62(8),801-807)
2020 | Year | 10 | Month | 16 | Day |
Delay expected |
Under submission
2020 | Year | 08 | Month | 19 | Day |
Completed
2017 | Year | 11 | Month | 07 | Day |
2017 | Year | 11 | Month | 15 | Day |
2017 | Year | 12 | Month | 01 | Day |
2018 | Year | 05 | Month | 07 | Day |
This is a retrospective study about persistence rate of out-patients visit. We collect and analyze Phase1 and Phase 2 data whose follow up period are until November 2016 and until November 2017 respectively.
2017 | Year | 11 | Month | 29 | Day |
2020 | Year | 10 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034418
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |